MedTrace Logo

Single Dose of Etomidate and Adrenal Cortex

NCT01792037 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2013-08-26

No results posted yet for this study

Summary

we aim to evaluate the effects of single dose of etomidate or use of steroid prior to etomidate during emergency intubation on hemodynamics and adrenal cortex.

Conditions

  • Adrenocortical Deficiency
  • Hemodynamic Instability

Interventions

DRUG

Etomidate

DRUG

Midazolam

DRUG

methylprednisolone

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Fatis Altindas, Prof. · Chairman of the Department of Anesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01792037 on ClinicalTrials.gov